Page last updated: 2024-09-04

aclacinomycin and spirogermanium

aclacinomycin has been researched along with spirogermanium in 1 studies

Compound Research Comparison

Studies
(aclacinomycin)
Trials
(aclacinomycin)
Recent Studies (post-2010)
(aclacinomycin)
Studies
(spirogermanium)
Trials
(spirogermanium)
Recent Studies (post-2010) (spirogermanium)
1688217280

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asbury, RF; Cnaan, A; Haller, DG; Harris, J; Johnson, L; Zaentz, SD1

Trials

1 trial(s) available for aclacinomycin and spirogermanium

ArticleYear
An Eastern Cooperative Oncology Group phase II study of single agent DHAD, VP-16, aclacinomycin, or spirogermanium in metastatic pancreatic cancer.
    American journal of clinical oncology, 1994, Volume: 17, Issue:2

    Topics: Aclarubicin; Adenocarcinoma; Adjuvants, Immunologic; Antineoplastic Agents; Etoposide; Female; Humans; Male; Mitoxantrone; Organometallic Compounds; Pancreatic Neoplasms; Spiro Compounds; Survival Rate

1994